DK1513834T3 - Substituted thiophenes, methods for their preparation, their use as a drug or diagnostic, and drug containing them - Google Patents

Substituted thiophenes, methods for their preparation, their use as a drug or diagnostic, and drug containing them

Info

Publication number: DK1513834T3
Authority: DK; Denmark
Prior art keywords: drug; diagnostic; preparation; methods; substituted thiophenes
Prior art date: 2002-06-04

Application number

DK03740148T

Other languages

Danish (da)

Inventor

Hans-Jochen Lang

Uwe Heinelt

Armin Hofmeister

Klaus Wirth

Michael Gekle

Markus Bleich

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-04

Filing date

2003-05-26

Publication date

2006-07-17

2003-05-26 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2006-07-17 Application granted granted Critical

2006-07-17 Publication of DK1513834T3 publication Critical patent/DK1513834T3/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)

DK03740148T 2002-06-04 2003-05-26 Substituted thiophenes, methods for their preparation, their use as a drug or diagnostic, and drug containing them DK1513834T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10224892A DE10224892A1 (en)	2002-06-04	2002-06-04	Substituted thiophenes, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them

Publications (1)

Publication Number	Publication Date
DK1513834T3 true DK1513834T3 (en)	2006-07-17

Family

ID=29557542

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03740148T DK1513834T3 (en)	2002-06-04	2003-05-26	Substituted thiophenes, methods for their preparation, their use as a drug or diagnostic, and drug containing them

Country Status (32)

Country	Link
EP (1)	EP1513834B1 (en)
JP (1)	JP4511924B2 (en)
KR (1)	KR101087966B1 (en)
CN (1)	CN1324024C (en)
AR (1)	AR040239A1 (en)
AT (1)	ATE320425T1 (en)
AU (1)	AU2003273553B2 (en)
BR (1)	BR0311548A (en)
CA (1)	CA2488242C (en)
CR (1)	CR7577A (en)
DE (2)	DE10224892A1 (en)
DK (1)	DK1513834T3 (en)
EC (1)	ECSP045471A (en)
ES (1)	ES2258722T3 (en)
HR (1)	HRP20041153A2 (en)
IL (1)	IL165519A (en)
MA (1)	MA27204A1 (en)
ME (1)	MEP27608A (en)
MX (1)	MXPA04011986A (en)
MY (1)	MY129832A (en)
NO (1)	NO329351B1 (en)
OA (1)	OA12827A (en)
PE (1)	PE20040534A1 (en)
PL (1)	PL372589A1 (en)
PT (1)	PT1513834E (en)
RS (1)	RS51141B (en)
RU (1)	RU2315766C2 (en)
TN (1)	TNSN04240A1 (en)
TW (1)	TWI283675B (en)
UA (1)	UA77551C2 (en)
WO (1)	WO2003101984A1 (en)
ZA (1)	ZA200409095B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040242560A1 (en)	2003-05-22	2004-12-02	Aventis Pharma Deutschland Gmbh	Process for synthesizing heterocyclic compounds
DE10323701A1 (en)	2003-05-22	2004-12-23	Aventis Pharma Deutschland Gmbh	Process for the synthesis of heterocyclic compounds
EP1640361B9 (en)	2003-06-30	2015-11-04	Sumitomo Chemical Company, Limited	Asymmetric urea compounds and process for producing asymmetric compounds by asymmetric conjugate addition reaction using the same as catalyst
EP2088861A4 (en) *	2006-10-25	2010-07-07	Takeda Pharmaceutical	BENZIMIDAZOLE COMPOUNDS
EP2342178B1 (en)	2008-09-02	2016-09-28	Sanofi	Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
RU2373929C1 (en) *	2008-11-11	2009-11-27	Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА)	Haemostasis system corrector manifesting inhibitory action on adhesive aggregative function of thrombocytes to prevent pathological thrombosis
WO2011058139A1 (en) *	2009-11-12	2011-05-19	Selvita Sp. Z O. O.	A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
RU2518740C1 (en) *	2013-03-22	2014-06-10	Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ"	METHOD, INHIBITING Na+/H+-EXCHANGE, AND DIHYDROCHLORIDE OF 2-(3,4-METHYLENEDIOXYPHENYL)-9-MORPHOLINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE
ME03311B (en)	2014-07-25	2019-10-20	Taisho Pharmaceutical Co Ltd	Phenyl tetrahydroisoquinoline compound substituted with heteroaryl
KR102840252B1 (en) *	2023-04-27	2025-07-30	한국화학연구원	Cyanobenzimidazole derivatives, pharmaceutically acceptable salt thereof, process for preparation thereof and pharmaceutical composition containing the same as an active ingredient
WO2025067474A1 (en) *	2023-09-28	2025-04-03	四川大学华西医院	Pyridine-containing compound, preparation method therefor, and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE754935A (en)	1969-08-13	1971-02-17	Hoechst Ag	2- (THIENYL-3'-AMINO) -1,3-DIAZACYCLOALCENES AND THEIR PREPARATION
BR6915362D0 (en) *	1969-08-16	1973-01-04	Hoechst Ag	PROCESS FOR THE PREPARATION OF 2 (TIENIL-3-AMINO) 1,3-DIAZACYCLEALCHENE
DE2830279A1 (en) *	1978-07-10	1980-01-31	Boehringer Sohn Ingelheim	2-CORNER CLAMP ON N- (2'-CHLOR-4'-METHYL-THIENYL-3 ') - N- (CYCLOPROPYLMETHYL) - AMINO CORNER CLAMP ON-IMIDAZOLINE- (2), THE ACID ADDITION SALTS THAT IT INCLUDES HIS PRODUCTION
US5395847A (en) *	1993-12-02	1995-03-07	Smithkline Beecham Corporation	Imidazolyl-alkenoic acids
WO2000006169A1 (en) *	1998-07-29	2000-02-10	Merck & Co., Inc.	Integrin receptor antagonists
DE19921883A1 (en) *	1999-05-12	2000-11-16	Bayer Ag	New thienylcycloalkylamino-1,3,5-triazine and thienylcycloalkenylamino-1,3,5-triazine derivatives are herbicides useful as desiccants and defoliants and especially for weed control
DE19960204A1 (en) *	1999-12-14	2001-06-28	Aventis Pharma Gmbh	Substituted norlbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
DK1499311T3 (en) *	2002-03-29	2010-03-08	Novartis Vaccines & Diagnostic	Substituted benzols and their use as RAF kinase inhibitors

2002
- 2002-06-04 DE DE10224892A patent/DE10224892A1/en not_active Withdrawn
2003
- 2003-05-26 RU RU2004138812/04A patent/RU2315766C2/en not_active IP Right Cessation
- 2003-05-26 RS YUP-1038/04A patent/RS51141B/en unknown
- 2003-05-26 UA UA20041211000A patent/UA77551C2/en unknown
- 2003-05-26 CN CNB038128462A patent/CN1324024C/en not_active Expired - Fee Related
- 2003-05-26 JP JP2004509675A patent/JP4511924B2/en not_active Expired - Fee Related
- 2003-05-26 DE DE50302673T patent/DE50302673D1/en not_active Expired - Lifetime
- 2003-05-26 KR KR1020047019725A patent/KR101087966B1/en not_active Expired - Fee Related
- 2003-05-26 HR HR20041153A patent/HRP20041153A2/en not_active Application Discontinuation
- 2003-05-26 DK DK03740148T patent/DK1513834T3/en active
- 2003-05-26 CA CA2488242A patent/CA2488242C/en not_active Expired - Fee Related
- 2003-05-26 ES ES03740148T patent/ES2258722T3/en not_active Expired - Lifetime
- 2003-05-26 PT PT03740148T patent/PT1513834E/en unknown
- 2003-05-26 EP EP03740148A patent/EP1513834B1/en not_active Expired - Lifetime
- 2003-05-26 PL PL03372589A patent/PL372589A1/en not_active Application Discontinuation
- 2003-05-26 BR BR0311548-8A patent/BR0311548A/en not_active IP Right Cessation
- 2003-05-26 AU AU2003273553A patent/AU2003273553B2/en not_active Ceased
- 2003-05-26 MX MXPA04011986A patent/MXPA04011986A/en active IP Right Grant
- 2003-05-26 ME MEP-276/08A patent/MEP27608A/en unknown
- 2003-05-26 AT AT03740148T patent/ATE320425T1/en active
- 2003-05-26 OA OA1200400321A patent/OA12827A/en unknown
- 2003-05-26 WO PCT/EP2003/005465 patent/WO2003101984A1/en not_active Ceased
- 2003-05-30 PE PE2003000531A patent/PE20040534A1/en not_active Application Discontinuation
- 2003-06-02 AR ARP030101958A patent/AR040239A1/en active IP Right Grant
- 2003-06-02 TW TW092114860A patent/TWI283675B/en not_active IP Right Cessation
- 2003-06-03 MY MYPI20032052A patent/MY129832A/en unknown
2004
- 2004-11-10 ZA ZA200409095A patent/ZA200409095B/en unknown
- 2004-11-16 MA MA27952A patent/MA27204A1/en unknown
- 2004-11-19 CR CR7577A patent/CR7577A/en unknown
- 2004-12-02 IL IL165519A patent/IL165519A/en not_active IP Right Cessation
- 2004-12-02 EC EC2004005471A patent/ECSP045471A/en unknown
- 2004-12-03 TN TNP2004000240A patent/TNSN04240A1/en unknown
- 2004-12-16 NO NO20045504A patent/NO329351B1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR101087966B1 (en)	2011-12-01
CR7577A (en)	2005-06-16
RS51141B (en)	2010-10-31
MY129832A (en)	2007-05-31
MA27204A1 (en)	2005-01-03
RU2004138812A (en)	2005-07-20
HRP20041153A2 (en)	2005-06-30
MEP27608A (en)	2010-06-10
EP1513834B1 (en)	2006-03-15
JP4511924B2 (en)	2010-07-28
MXPA04011986A (en)	2005-03-07
AU2003273553B2 (en)	2008-12-04
PE20040534A1 (en)	2004-10-25
UA77551C2 (en)	2006-12-15
TW200406409A (en)	2004-05-01
CA2488242C (en)	2011-08-02
CN1324024C (en)	2007-07-04
AR040239A1 (en)	2005-03-23
PT1513834E (en)	2006-06-30
ECSP045471A (en)	2005-01-28
RU2315766C2 (en)	2008-01-27
DE50302673D1 (en)	2006-05-11
CA2488242A1 (en)	2003-12-11
KR20050005532A (en)	2005-01-13
WO2003101984A1 (en)	2003-12-11
IL165519A (en)	2010-05-31
TNSN04240A1 (en)	2007-03-12
DE10224892A1 (en)	2003-12-18
NO20045504L (en)	2005-01-25
CN1659163A (en)	2005-08-24
IL165519A0 (en)	2006-01-15
PL372589A1 (en)	2005-07-25
ZA200409095B (en)	2005-05-10
BR0311548A (en)	2005-04-12
TWI283675B (en)	2007-07-11
HK1076460A1 (en)	2006-01-20
EP1513834A1 (en)	2005-03-16
OA12827A (en)	2006-07-11
ES2258722T3 (en)	2006-09-01
ATE320425T1 (en)	2006-04-15
AU2003273553A1 (en)	2003-12-19
RS103804A (en)	2006-12-15
JP2005533038A (en)	2005-11-04
NO329351B1 (en)	2010-10-04

Publication	Publication Date	Title
DK1558600T3 (en)	2008-09-01	Selected CGRP antagonists, methods of preparation thereof, and their use as a drug
DK1732917T3 (en)	2009-11-30	Selected CGRP antagonists, processes for their preparation, and their use as a drug
DK1953162T3 (en)	2012-09-10	Xanthine derivatives, their preparation and their use as a drug.
DK1532149T3 (en)	2010-05-10	8- [3-Amino-piperiden-1-yl] -xanthines, their preparation and their use as a drug
DK1294682T3 (en)	2004-08-02	Acylphenylurea derivatives, processes for their preparation and their use as a drug
DK1562946T3 (en)	2010-09-20	New xanthine derivatives, their preparation and their use as a drug
DK1673352T3 (en)	2009-07-06	Sulfoxime substituted pyrimidines as CDK and / or VEGF inhibitors, their preparation and use as a drug
DK1730131T3 (en)	2012-08-13	Glucopyranosyl-substituted benzene derivatives, drug containing these compounds, their use and methods for their preparation
NO20052493D0 (en)	2005-05-24	Selected CGRP antagonists, processes for their preparation and their use as pharmaceutical compositions.
DK1218341T3 (en)	2005-12-12	Sulfonylcarboxamide derivatives, process for their preparation and their use as a drug
NO20032735L (en)	2003-08-06	Diphenyllazetidinone derivatives, process for their preparation, drugs containing these compounds and their use
NO20044322L (en)	2004-10-12	Benzoxanone-derived compounds, their preparation and use as a drug
NO20052739D0 (en)	2005-06-07	CCR5 antagonists as drugs
DK1670458T3 (en)	2007-04-23	1-Amino-2-oxy-substituted tetrahydronaphthalane derivatives, processes for their preparation and their use as antiphlogistics
NO20054329D0 (en)	2005-09-20	Adamantan derivatives, processes for their preparation, and pharmaceutical compositions which include them
DK1492789T3 (en)	2006-09-11	Tropane derivatives as CCR5 modulators
DK1445252T3 (en)	2006-06-19	Sulfonamide derivatives, their preparation and use as drugs
DK1222163T3 (en)	2006-11-13	2'-Substituted 1,1'-biphenyl-2-carboxamides, methods of preparation thereof, their use as a medicament, and pharmaceutical compositions containing them
NO20005146L (en)	2000-12-14	Thienylazolylalkoxyethanamines, their preparation and their use as drugs
DK1453810T3 (en)	2009-07-20	Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as a drug containing the same
DK1513834T3 (en)	2006-07-17	Substituted thiophenes, methods for their preparation, their use as a drug or diagnostic, and drug containing them
NO20054876D0 (en)	2005-10-21	Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as drug and drug containing such compounds
DK1509498T3 (en)	2007-02-26	Pentafluorosulfanyl benzoylguanidines, processes for their preparation, use thereof as a medicament or diagnostic, and medicament containing them
NO20022801D0 (en)	2002-06-12	Substituted norbornylamino derivatives, process for their preparation, their use as a drug or diagnostic as well as drugs containing these
DK1838315T3 (en)	2014-06-16	SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, METHOD OF PREPARING IT, THEIR USE AS MEDICINE AND MEDICINES CONTAINING THEM